KOCAA
NVAX icon

Knights of Columbus Asset Advisors’s Novavax NVAX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,409
Closed -$724K – 316
2021
Q2 		$724K Buy
3,409
+32
+0.9% +$5.86K 0.07% 235
2021
Q1 		$612K Buy
+3,377
New +$673K 0.06% 259

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knights of Columbus Asset Advisors's NVAX Position: Q3 2021 in Review

Knights of Columbus Asset Advisors sold out of Novavax (NVAX) in Q3 2021, closing a stake of 3,409 shares — an estimated $724K sold.

Knights of Columbus Asset Advisors first reported a position in NVAX in Q1 2021 and held it in 2 quarters. The position peaked at $724K in Q2 2021. 443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • Knights of Columbus Asset Advisors reported no remaining Novavax position as of Q3 2021 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 3,409 Novavax shares in Q3 2021, an estimated $724K.
  • Knights of Columbus Asset Advisors first reported a position in Novavax in Q1 2021 and held it in 2 quarters.
  • Knights of Columbus Asset Advisors's Novavax position peaked at $724K in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.